Clinical Laboratory in Massachusetts

JEOL Ltd. is a global manufacturer of scientific instruments, semiconductor equipment, industrial systems, and medical laboratory analyzers established in 1949. The company specializes in electron microscopy (transmission electron microscopes [TEM], scanning electron microscopes [SEM], field-emission SEMs), nuclear magnetic resonance (NMR) spectrometers, mass spectrometers (including AccuTOF-DART systems), and electron beam lithography systems for semiconductor manufacturing and research. JEOL also manufactures electron beam metal additive manufacturing (AM) systems, cross-section polishers (including the IB-19540CP and IB-19550CCP models), and clinical chemistry analyzers for laboratory applications. Primary markets include life science research (molecular biology, drug discovery, cryo-electron microscopy), semiconductor device characterization and manufacturing, materials science, industrial processing, and clinical diagnostics. The company serves universities, research institutions, semiconductor manufacturers, and medical laboratories worldwide. JEOL maintains regional operations across North America, Europe, Asia-Pacific, and the Middle East, with product lines tailored to semiconductor yield optimization, advanced materials characterization, structural biology research, and diagnostic chemistry. The company emphasizes high-resolution imaging, elemental analysis, spectroscopic capabilities, and integration of analytical workflows for research and production environments.

Boston Cell Standards Inc develops calibration and quality control solutions for immunohistochemistry (IHC) testing, a critical diagnostic method in cancer diagnosis and treatment stratification. The company manufactures IHCalibrators® and IHControls®—quantitative reference standards and quality control products designed to standardize and improve the accuracy and consistency of IHC assays across laboratory systems and sites. BCS products are used in clinical pathology laboratories for assay validation, lot-to-lot and instrument-to-instrument alignment, troubleshooting, and proficiency testing, as well as in pharmaceutical and life sciences settings for drug development and clinical trial consistency. The company received FDA clearance for its IHControl® panel—the first FDA-cleared quantitative control for anatomic pathology in breast cancer—and collaborates with the National Institute of Standards and Technology (NIST) to establish measurement traceability and reference standards for IHC. Boston Cell Standards is ISO 13485 certified and has received over $9 million in funding from the National Cancer Institute (NIH) spanning more than 20 years. The company has established the Consortium for Analytic Standardization in Immunohistochemistry (CASI) to advance IHC quality standards. Research published in peer-reviewed journals including Lancet: eBioMedicine, Laboratory Investigation, and American Journal of Surgical Pathology validates the effectiveness of BCS technology in improving analytical sensitivity and reducing inter-lab variability in breast cancer HER2 testing and other oncologic diagnostics.

Associates of Cape Cod, Inc. (ACC) is a specialist manufacturer of endotoxin and glucan testing reagents, instrumentation, and software for pharmaceutical, biological product, and medical device manufacturers. The company's primary product portfolio centers on Limulus Amebocyte Lysate (LAL) reagents—derived from horseshoe crab blood—used to detect bacterial endotoxins in injectable pharmaceuticals, biologics, and medical devices. ACC also manufactures recombinant endotoxin testing (rBET) alternatives, including recombinant cascade reagents, positioning itself as a supplier of both traditional and next-generation pyrogen detection solutions. The Pyros® eXpress software platform provides integrated quantitative analysis and data management for endotoxin and glucan detection testing across glass tube and plate reader formats, with documented compatibility with Agilent BioTek Epoch 2 microplate readers. ACC operates a Contract Test Services (CTS) laboratory offering third-party endotoxin and glucan contamination testing. The company supports customers through free consultation, methodology guidance, and technical training. ACC maintains a demonstrated commitment to sustainability, including the Horseshoe Crab Sustainability Project (having reared and released over 1 million juvenile horseshoe crabs) and environmental responsibility in manufacturing. The company supplies the regulated biomedical testing market, serving manufacturers of injectable drugs, biologics, and medical devices requiring endotoxin testing for regulatory compliance (FDA, pharmacopeial).

Mossman Associates, Inc. is a medical device company that develops and distributes two primary product lines: the Biosound Therapy System and the NicCheck I urine nicotine test. The Biosound Therapy System is a vibrational therapy platform that integrates biofeedback, sound frequency healing, music therapy, and guided imagery. The system consists of a memory foam platform integrated with audio/visual delivery that utilizes precisely choreographed music synchronized with low-frequency sine tones and binaural beats. The NicCheck I is an FDA-cleared (510(k): K963733) and CLIA-waived urine dipstick test designed to measure nicotine and nicotine metabolites in clinical and professional environments. The company markets NicCheck I as the only FDA-cleared and CLIA-waived nicotine test available. Mossman Associates serves healthcare providers, clinical facilities, occupational health programs, and wellness centers. The company provides comprehensive provider resources, testimonials, research documentation, and clinical support materials for both product lines. Distribution and ordering capabilities are available through their website.

Tekscan, Inc. designs and manufactures patented force measurement, pressure mapping, and tactile sensing solutions for clinical, research, and industrial applications. The company specializes in real-time pressure and temperature visualization systems used to measure and analyze force distribution between or across surfaces. Core product lines include pressure mapping systems for clinical assessment and R&D optimization, embedded flexible force sensors (FlexiForce) engineered for OEM device integration, and temperature mapping systems that correlate thermal and pressure data. A key clinical product is T-Scan Novus, a digital occlusal analysis system for dental applications that evaluates bite force, occlusion, and timing. Tekscan's solutions serve biomechanics research, dental diagnostics, orthopedic assessment, rehabilitation evaluation, automotive and manufacturing quality control, battery optimization, and electronics/semiconductor process validation. The company provides custom sensor design, rapid prototyping, and engineering consultation through TactileLab. Products are used by clinicians to improve patient outcomes and by engineers in R&D and quality control to validate designs and ensure repeatable performance. Tekscan was acquired by Uneo, Inc. in November 2025 and operates as part of the Tekscan Group. The company maintains technical support services, product training, and calibration capabilities.

Foundation Medicine is a precision oncology diagnostics company specializing in comprehensive genomic profiling (CGP) and companion diagnostic testing for advanced cancer patients. The company develops and commercializes FDA-approved next-generation sequencing (NGS) based in vitro diagnostic tests, including FoundationOne®CDx (tissue-based) and FoundationOne®Liquid CDx (blood-based, circulating cell-free DNA). FoundationOne CDx analyzes 324 genes plus genomic signatures from formalin-fixed, paraffin-embedded (FFPE) tissue samples. FoundationOne Liquid CDx analyzes 324 genes using plasma specimens, reporting short variants in 311 genes, rearrangements in 8 genes, and copy number alterations in 3 genes. Foundation Medicine also offers FoundationOne Heme testing and IHC (immunohistochemistry) services. The company serves three core markets: healthcare providers and oncologists seeking biomarker-driven treatment selection; biopharmaceutical and research partners requiring companion diagnostic development, clinical trial support, and regulatory expertise across the drug development lifecycle; and patients seeking personalized cancer treatment guidance. Foundation Medicine operates a global laboratory with comprehensive EMR integration capabilities and provides decision support services and educational resources to clinicians. The company has delivered over 1.5 million genomic profiling reports and holds more than 50% of all approved US companion diagnostic indications for NGS testing. Services span discovery and translational research, clinical development and CDx strategy, and access and commercialization support. The company is FDA-regulated and maintains rigorous quality standards for molecular diagnostics.

AB Sciex LLC is a global leader in mass spectrometry and capillary electrophoresis solutions for research, clinical diagnostics, and life sciences applications. The company manufactures a comprehensive portfolio of analytical instruments including triple-quadrupole and QTOF mass spectrometers, HPLC-MS systems, and capillary electrophoresis (CE) instruments. SCIEX serves clinical diagnostic laboratories with FDA-cleared in vitro diagnostic (IVD) medical devices for routine testing; pharmaceutical and biopharmaceutical companies for drug development and biologics characterization; contract research organizations for bioanalysis; environmental and food safety testing facilities; and life science research institutions. Core product lines include the Triple Quad 7500 Plus system, ZenoTOF 7600 QTOF system, Citrine clinical IVD mass spectrometers, ExionLC front-end HPLC systems, and Intabio ZT for charge variant analysis. SCIEX OS is the company's proprietary software platform supporting Windows 11 for data acquisition, processing, and instrument control. The company emphasizes speed, sensitivity, resolution, and ease of adoption across routine and complex analytical workflows. Manufacturing and support operations span multiple global regions, with primary headquarters in Marlborough, MA, and sales/service in Redwood City, CA (Americas) and multiple EMEA locations.

Miltenyi Biotec is a biotech company specializing in cell isolation, separation, and analysis technologies for research and clinical applications. The company manufactures MACS® (Magnetic Cell Separation) systems and reagents for isolating and purifying specific cell populations from complex samples. Key product lines include MicroBead Kits (e.g., StraightFrom Spleen kits for rapid immune cell isolation from mouse tissue in 15 minutes), flow cytometry instruments and software (MACSQuantify with express modes for standardized, automated workflows), and imaging analysis software (MACS iQ View 3D for large-volume image datasets). The company also offers the MACS Catalyst Program, providing guidance, instrument placement, and regulatory support (IND pathways) for cell and gene therapy developers in North America. Products target research institutions, clinical laboratories, and cell therapy manufacturers. The company supports procurement via purchase orders and maintains an online product catalog. While the fetched content does not explicitly detail FDA clearances or ISO certifications, Miltenyi Biotec is known for manufacturing life science research tools and clinical-grade cell separation systems used in regulated environments. Headquarters appear to be in Germany (Bergisch Gladbach, Rhineland) with North American operations.

Precision Systems, Inc. manufactures osmometers and related laboratory analytical instruments for clinical, neonatal, veterinary, dairy, petroleum, and chemistry applications. The company specializes in osmometry—the measurement of osmotic pressure in biological and chemical samples—and offers a range of automatic and semi-automatic osmometer models with varying sample volumes (10–50 µL) and throughput capabilities. Product lines include the OSMETTE series (manual/automatic variants), the Micro OSMETTE (high-sensitivity), the Multi-OSMETTE (auto-sampling turntable), and the Touch Micro OSMETTE (touchscreen interface). These instruments are used in clinical laboratories for serum and urine osmolality testing, neonatal screening, and industrial quality control. Precision Systems positions itself as an industry leader in measurement accuracy and reliability. The company maintains a direct-to-customer e-commerce presence and offers service and support. No explicit regulatory certifications (FDA 510(k), ISO 13485, CE Mark) are mentioned on the accessible portions of the website.

Boca Scientific Inc is a premier distributor of advanced biotechnology reagents, kits, and laboratory supplies for research institutions across the United States and Canada. The company curates a specialized selection of molecular biology, immunology, cell biology, and diagnostic products sourced from leading manufacturers in Europe, Asia, and the Americas. Product offerings encompass DNA polymerases, PCR reagents, cell culture media, transfection reagents, DNA/RNA purification and isolation kits, antibodies, protein markers, immunoassay optimization reagents, western blotting supplies, vector systems, freezer storage solutions, and laboratory instrumentation. Boca Scientific serves academic research labs, biotech firms, and diagnostic laboratories with high-quality consumables and equipment supporting genomics, cell biology, and molecular research workflows.

binx health is a molecular diagnostics company specializing in point-of-care testing platforms for sexually transmitted infections and other infectious diseases. The company's flagship product, binx io, is an FDA-cleared, CLIA-waived molecular platform enabling single-visit diagnosis and treatment of chlamydia and gonorrhea infections with 30-minute time-to-results. binx io delivers rapid molecular diagnostics in clinical settings including urgent care, primary care clinics, sexual health clinics, and community health centers, supporting both male and female patients. The platform has established reimbursement pathways and is distributed nationally through partnerships with major healthcare distributors including Cardinal Health and Afaxys. binx health also developed binx everywhere, an at-home self-collection testing platform for STI and HPV screening. The company operates a reagent rental model and supplies molecular reagents to decentralized testing locations. binx health's point-of-care diagnostic solutions are designed to expand equitable access to healthcare, reduce traditional barriers to care, and enable rapid diagnosis-and-treatment workflows in community settings. The company has received regulatory clearance, strategic partnerships with healthcare systems, nonprofit organizations, and public health agencies, and recognition as a digital health innovator.

MetaSystems International GmbH is a global developer and manufacturer of automated microscopy system software and hardware, headquartered in Germany with operations established since 1986. The company serves clinical laboratories and research institutions across 103 countries with solutions for automated image capture, analysis, and workflow management in cytology and pathology applications. Primary product lines include the Metafer automated microscopy platform with AI-enabled imaging modules (sperm detection, forensic casework support) and the Ikaros image analysis system. MetaSystems also maintains a separate Probes division (MetaSystems Probes GmbH) specializing in XCyting DNA fluorescence probes for FISH and molecular diagnostics. The company is recognized for developing deep neural network-based imaging solutions, recently granted an EU patent for AI imaging technology. Products are marketed to forensic pathology, clinical cytology, and hematology laboratories. MetaSystems operates subsidiary offices and authorized distribution partners across major regions including USA, Latin America, Italy, India, China, Hong Kong, and Japan, with direct support teams in Germany.

Waters Corporation is a global manufacturer of analytical laboratory instruments, consumables, software, and services headquartered in Milford, Massachusetts. The company specializes in chromatography, mass spectrometry, and sample preparation technologies for pharmaceutical, biopharmaceutical, clinical diagnostics, and life science research applications. Waters' product portfolio includes liquid chromatography (LC) and ultra-performance liquid chromatography (UPLC) systems, mass spectrometry instruments, columns, sample preparation and filtration supplies, and laboratory informatics software. Key product lines include the BioAccord System for biotherapeutic analysis, Xevo mass spectrometers for bioanalytical applications, and biphenyl columns with MaxPeak HPS technology for enhanced separation. The company serves biopharma and pharma development, clinical research and diagnostics, food and beverage testing, forensics, environmental analysis, and cannabis testing markets. Waters provides comprehensive services including instrument support, technical training, application development, and the FlexUP Technology Trade-In Program. The company recently combined with BD Biosciences and Diagnostic Solutions, and received FDA clearance for an at-home cervical cancer screening tool. Waters operates a global distribution network and maintains regulatory compliance across major markets. The company offers online shopping, customized quoting, educational resources, and multi-channel customer support.

BioView is a leading developer and manufacturer of automated cell imaging and analysis solutions for cytogenetics, oncology, and pathology laboratories. With nearly two decades of expertise, BioView specializes in diagnostic automation technology, particularly automated FISH (Fluorescence In Situ Hybridization) imaging and analysis. The company's comprehensive product portfolio includes the Cytogenetics Suite featuring automated karyotyping and FISH imaging platforms, as well as scanning systems ranging from manual workstations to fully automated loaders. BioView offers FDA-cleared and CE-marked applications for diverse diagnostics including hematology, prenatal testing, circulating tumor cell detection, and oncology applications. The company provides web-based analysis tools enabling case analysis and reporting from any location without software installation. BioView's systems are designed to enhance laboratory efficiency, accuracy, and standardization across diverse clinical and research workflows.

Viant Medical is a vertically integrated contract manufacturing partner specializing in medical device design, development, and full-scale production. The company operates 25 global locations with 2.3 million square feet of factory space, including 299,000+ square feet of ISO-certified clean room capacity. Viant serves OEMs across multiple clinical markets: orthopedics (instruments, implants, delivery systems, UHMWPE components), surgical technologies (minimally invasive surgery, robotics, endoscopy, ophthalmology, wound care, biopsy, aesthetic surgery), cardiac and interventional devices (overmolding, nitinol tubing, hypotube precision components), drug delivery (auto-injectors, IV sets, connectors, respiratory devices), bioprocessing (containment, transfer, filtration systems), bioelectronics (pain management, sleep apnea, wearables), diagnostics and laboratory products (injection tubes, chromatography tubing), and respiratory/monitoring/patient care (masks, trach tubes, airway tubes, console components). Core manufacturing capabilities include precision metals and metal tubing, medical-grade plastics and silicone molding, extrusions, tooling, automation, device assembly, and finished device services. The company provides end-to-end solutions from prototyping through sterilization and packaging management. Viant emphasizes vertical integration to ensure quality control, reduce supply chain risk, and accelerate time-to-market. The ViaLaunch™ program offers program management support. The company focuses exclusively on medical device manufacturing and maintains operational expertise in complex assembly, overmolding, and materials science.

Product Resources is a US-based contract engineering and manufacturing company specializing in complex scientific instrumentation, medical devices, and industrial automation. Founded in 1979 and based in Newburyport, Massachusetts, the company provides end-to-end design and manufacturing services including product design, prototype development, design for manufacturability, regulatory compliance, pilot production, and full-scale manufacturing with assembly and testing. The company is FDA-registered and ISO 13485:2016 certified for medical device manufacturing, with additional ISO 9001:2015 certification and specialized expertise in design and manufacturing for explosive atmospheres (UL913, ATEX). Product Resources has manufactured diverse products including microfluidic dispensing systems, dental laser instruments, surgical robot navigation systems, pharmaceutical process equipment, cryogenic sample preparation devices, automated chemistry lab equipment, and control systems for medical devices. The company serves OEMs, medical device manufacturers, and technical startups across North America, Europe, and Japan, with approximately half of products exported globally.